Teresa Aja

发表

Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modifications.

J. Díaz, A. Schmitz, T. Deckwerth, 2003, Bioorganic & medicinal chemistry letters.

First-in-class pan caspase inhibitor developed for the treatment of liver disease.

N. Chen, J. Díaz, K. Valentino, 2005, Journal of medicinal chemistry.

Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke.

A. Sauter, J. Díaz, A. Schmitz, 2004, Bioorganic & medicinal chemistry letters.

Chemically programmed antibodies: endothelin receptor targeting CovX-Bodies.

C. Barbas, Lingna Li, F. Liao, 2007, Bioorganic & medicinal chemistry letters.

Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads.

N. Chen, J. Díaz, A. Schmitz, 2005, Bioorganic & medicinal chemistry letters.

Activation of the CED3/ICE-Related Protease CPP32 in Cerebellar Granule Neurons Undergoing Apoptosis But Not Necrosis

E. Alnemri, R. Armstrong, L. Fritz, 1997, The Journal of Neuroscience.

Activation of Membrane-associated Procaspase-3 Is Regulated by Bcl-2

A. Schmitz, R. Armstrong, L. Fritz, 1999, The Journal of cell biology.

Fas-induced Activation of the Cell Death-related Protease CPP32 Is Inhibited by Bcl-2 and by ICE Family Protease Inhibitors*

S. Korsmeyer, J. Xiang, R. Armstrong, 1996, The Journal of Biological Chemistry.

Long‐term protection of brain tissue from cerebral ischemia by peripherally administered peptidomimetic caspase inhibitors

M. Rudin, A. Sauter, A. Schmitz, 2001 .